Glyxambi
Linagliptin with empagliflozin as a film-coated tablet, used in the management of type 2 diabetes mellitus. A DPP-4 inhibitor with an SGLT2 inhibitor.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 25/5mg | 30 tablets | $153.00 | $5.10 |
| 25/5mg | 60 tablets | $301.20 | $5.02 |
| 25/5mg | 90 tablets | $441.00 | $4.90 |
- Category
- Diabetes Management
- Active ingredients
- Linagliptin · Empagliflozin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 25/5mg
You will receive a quality generic equivalent, depending on stock.
No prescription needed: we place your order for Glyxambi on your behalf.
- Condition
- Type 2 Diabetes Mellitus
- Therapeutic class
- DPP-4 Inhibitor; SGLT2 Inhibitor
- Pharmacological class
- Gliptin; Gliflozin
- Precautions and warnings
- monitor for signs of ketoacidosis; maintain adequate hydration
- Minor side effects
- urinary tract infection; nasopharyngitis
- Moderate side effects
- genital infections; polyuria
- Serious side effects
- diabetic ketoacidosis, requires immediate medical attention
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Originator
- Boehringer Ingelheim
- Onset time
- 1–2 hours
- Duration
- 24 hours
- Storage instructions
- Store at room temperature below 30°C.
- Drug interactions
- insulin; sulfonylureas
- Age restrictions
- Adults only.
- Pregnancy and breastfeeding
- Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to components; type 1 diabetes; diabetic ketoacidosis; severe renal impairment
Patient summary
Linagliptin with empagliflozin as a film-coated tablet, used in the management of type 2 diabetes mellitus. A DPP-4 inhibitor with an SGLT2 inhibitor.
Mechanism of action
Glyxambi improves glucose control by combining two mechanisms. Linagliptin increases incretin hormone levels, enhancing insulin release. Empagliflozin prevents glucose reabsorption in the kidneys, causing excess sugar to be flushed through urine. Combined, these mechanisms improve glycemic stability without overstimulating insulin production in the body.
Glyxambi combines linagliptin and empagliflozin, a dual-action therapeutic approach for the management of Type 2 Diabetes Mellitus. This medication helps the pancreas produce insulin while simultaneously assisting the kidneys in removing excess sugar from the body. It is supplied as a tablet in the 25/5mg strength.
Buying Glyxambi online
Ordering online offers a straightforward alternative for expats and residents who may otherwise face difficulty sourcing specific tablets locally, or who prefer consistent access to their established treatment plan.
What you will receive
Glyxambi is the originator brand name, made by Boehringer Ingelheim. We use it here to identify the medicine only; we are not affiliated with Boehringer Ingelheim and do not ship the original Glyxambi.
- You receive a generic equivalent: the same active ingredient (Linagliptin / Empagliflozin) at the same dose, mostly recognised branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- Inactive ingredients, tablet appearance and packaging can differ from the original brand; the active ingredient and dose are the same.